Funding for this research was provided by:
Fund of Fujian Cancer Hospital (2021YN06)
Startup Fund for scientific research, Fujian Medical University (2018QH1223)
Bethune Ethicon Excellent Surgery Foundation (HZB-20181119-46)
Beijing Municipal Science and Technology Commission (Z151100004015105)
National Natural Science Foundation of China (81773214)
Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (ZYLX202116)
Received: 17 July 2022
Accepted: 6 November 2022
First Online: 21 November 2022
: This study was approved by the Medical Ethics Committee of Peking University Cancer Hospital. All the subjects provided written informed consent. And the methods were carried out in accordance with Ethical standards in the 1964 Declaration of Helsinki and its subsequent amendments.
: Informed consent to publish this work has been received from all participants.
: The authors declare no conflicts of interest.